High-Intensity Laser Therapy for Eosinophilic Fasciitis

Eosinophilic Fasciitis Clinical Trial

Official title:

Efficacy of High-Intensity Laser Therapy for the Management of Eosinophilic Fasciitis: A Case Report

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05915585
• Other study ID #: 010/012023
• Status: Recruiting
• Phase: N/A
• Start date: June 18, 2023
• Est. completion date: July 20, 2023

Study information

• Verified date: June 2023
• Source: Ahram Canadian University
• Contact: Mohamed M ElMeligie, Ph.d
• Phone: +201064442032
• Email: mohamed.elmeligie[@]acu.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Eosinophilic fasciitis (EF) is a rare musculoskeletal disorder characterized by inflammation and thickening of the fascia, leading to pain, stiffness, and functional impairment. Conventional treatment options include immunosuppressive medications, corticosteroids, and physical therapy. This case report will describe use of high-intensity laser therapy (HILT) using the Mectronic Exand MY high-intensity laser system in a patient with EF, highlighting its potential as an alternative or adjunct treatment option.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1
• Est. completion date: July 20, 2023
• Est. primary completion date: July 19, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients diagnosed with Eosinophilic fasciitis.

Exclusion Criteria:

• a diagnosis unrelated to Eosinophilic fasciitis

Related Conditions & MeSH terms

• Eosinophilia
• Eosinophilic Fasciitis
• Fasciitis

Intervention

Device:
• High-Intensity Laser Therapy
The patient will receive HILT using the Mectronic Exand MY high-intensity laser system with the following parameters: Wavelength: 1064 nm (near-infrared) Power: 12 W Energy density: 8 J/cm² Pulse duration: 200 µs Treatment duration: 10 minutes Frequency: 3 sessions per week for 4 weeks Total energy delivered: 96 J per treatment session

Locations

Country	Name	City	State
Egypt	Outpatient clinic of faculty of physical therapy, Ahram Canadian University	Al ?ayy Ath Thamin	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Ahram Canadian University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain intensity via Numeric pain rating scale		Changes in pain intensity at baseline and 4 weeks
Primary	Functional outcomes via Disabilities of the Arm, Shoulder and Hand questionnaire (DASH)		Changes in DASH at baseline and 4 weeks
Primary	Quality of life via Short Form-36 Health Survey		Changes in Short Form-36 Health Survey at baseline and 4 weeks
Primary	Adverse event	adverse events are recorded by the patient and therapist	4 Weeks